SCHEMBL28600244

SCHEMBL28600244

CC(C)(C)C(Cl)C(CC(=O)O)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.36
HMGCR P04035 1/20 0.36
CHRM1 P11229 1/20 0.36
TBXA2R P21731 1/20 0.36
ADRA1A P35348 1/20 0.36
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
HIF1A Q16665 1/20 0.34
SLC22A6 Q4U2R8 1/20 0.33
SLC1A3 P43003 1/20 0.33
SLC1A2 P43004 1/20 0.33
SLC1A1 P43005 1/20 0.33
CPT2 P23786 1/20 0.33
ACLY P53396 1/20 0.33
LMNA P02545 1/20 0.32
PGD P52209 1/20 0.32
KDM4E B2RXH2 1/20 0.31
FOLH1 Q04609 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10635301 0.76 SLC22A6 (0.40) TDP1SMN1; SMN2HMGCRCHRM1TBXA2R
SCHEMBL11720071 0.76 TDP1 (0.56) TDP1SMN1; SMN2HMGCRCHRM1TBXA2R
SCHEMBL8877734 0.74 TDP1 (0.54) TDP1SMN1; SMN2HMGCRCHRM1TBXA2R
SCHEMBL554957 0.74 TDP1 (0.68) TDP1SMN1; SMN2ADRA1ASLC22A6SLC1A3
SCHEMBL5514949 0.74 TDP1 (0.68) TDP1SMN1; SMN2ADRA1ASLC22A6SLC1A3
SCHEMBL14803500 0.74 TDP1 (0.68) TDP1SMN1; SMN2ADRA1ASLC22A6SLC1A3
SCHEMBL22151 0.72 TDP1 (1.00) TDP1SMN1; SMN2TSHRSLC22A6LMNA
SCHEMBL17517216 0.72 TDP1 (1.00) TDP1SMN1; SMN2TSHRSLC22A6LMNA
SCHEMBL16925719 0.72 TDP1 (1.00) TDP1SMN1; SMN2TSHRSLC22A6LMNA
SCHEMBL165643 0.72 TDP1 (1.00) TDP1SMN1; SMN2TSHRSLC22A6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112805000-A 2-arylbenzimidazoles as PPARGC1A activators for the treatment of neurodegenerative diseases 小利兰·斯坦福大学董事会 2021-05-14 CN disclosed